Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, along with Revision: v3.3.2. Removed the previous description stating PubMed publications are automatically created and Revision: v3.2.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer displays the standard government funding status notice. This change does not affect the study details or access, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo substantive changes to the study design, eligibility criteria, endpoints, or locations were detected between the screenshots. The updates appear to be minor formatting or metadata adjustments that do not affect the page’s purpose.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor update to operating-status notice and a version bump to v3.2.0; replaces v3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other substantive content changes were detected.SummaryDifference0.2%

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.